Chondroid lipoma in a child.

Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, Uttar Pradesh, India.
Indian Journal of Pathology and Microbiology (Impact Factor: 0.47). 01/2008; 51(4):541-2. DOI: 10.4103/0377-4929.43755
Source: PubMed


Chondroid lipoma (CL), a rare lipoma variant, has not been described well for patients younger than 14 years of age. We herein report an extremely unusual instance of CL in a 7-year-old child. The cut surface of the tumor showed peculiar tan-brown and yellow-white areas. Histopathological sections showed the presence of eosinophilic variably vacuolated round- to oval-spindle cells in a myxo-hyaline background. The findings were consistent with CL. The case is reported because of its extreme rarity.

3 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chondroid lipoma is a rare, benign soft tissue tumor with features of both embryonal fat and embryonal cartilage that most often arises in the proximal limb and limb girdles of adult women. Histologically, it comprises nests and cords of rounded cells with granular eosinophilic or multivacuolated, lipid-containing cytoplasm within prominent myxohyaline stroma and may be morphologically confused with some sarcomas. Correct diagnosis is crucial to avoid overtreatment because it does not recur or metastasize, and simple excision is curative. The etiology of chondroid lipoma remains unknown, but it appears genetically distinct, with a reciprocal t(11;16)(q13;p13) translocation identified in an increasing number of cases. We review the literature on chondroid lipoma, discussing tumor histology, immunohistochemistry, ultrastructure, and differential diagnosis, and summarize the molecular genetic features so far known.
    Annals of diagnostic pathology 06/2012; 16(3):230-4. DOI:10.1016/j.anndiagpath.2012.01.002 · 1.12 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chondroid lipoma is a rare benign fatty soft tissue tumor. Due to its morphological similarity it is important to distinguish it from extra skeletal chondro sarcoma and myxoid/round cell liposarcoma. It was first reported 20 years ago by Meis and Enzinger who described the histopathological features of this rare entity containing adipose tissue with mature fat cells and lipoblasts and cartilaginous tissue with chondroblasts and hyaline matrix1. Familiarity with the histopathological features of Chondroid lipoma is of practical importance to avoid an over diagnosis and subsequent over treatment. We report a similar case found on histopathological analysis of an excised breast tissue.
    Journal of the Liaquat University of Medical and Health Sciences 08/2013; 12(02).
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lipomatous tumours are rare in the head and neck region. Their biological behaviour varies greatly, from absolutely benign to histologically benign but locally infiltrative and, finally, invasive with metastatic potential. Each lipomatous tumour has to be treated accordingly. It is of paramount importance before eventual surgery is planned to perform adequate imaging, diagnostic biopsy and careful assessment. Only in small (<5 cm), superficial soft tissue tumours or when magnetic resonance imaging has demonstrated specific features of lipoma, may diagnostic biopsy be omitted. In these cases, expectant management or simple excision is appropriate. Adequate preoperative diagnosis is important to assure adequate tumour control as well as optimal functional and cosmetic outcome. The major problem in the treatment of lipomatous tumours of the head and neck region is the presence of nearby delicate structures. Especially, wide surgical excision of liposarcomas may be hindered by anatomic constraints and may result in impaired functional and cosmetic outcome. Neoadjuvant radiotherapy and specific systemic chemotherapy may be helpful in the treatment of liposarcoma, especially when unresectable or when primary surgery is expected to result in poor oncological, functional or cosmetic outcome. Greater emphasis placed on the underlying biology of individual sarcoma subtypes, development and evaluation of novel therapies and greater specificity in the selection of chemotherapy agents based on activity in individual histological subtypes are expected to lead to improved efficacy of systemic treatment.
    Archives of Oto-Rhino-Laryngology 05/2014; 272(5). DOI:10.1007/s00405-014-3065-8 · 1.55 Impact Factor